Effects of Annular Size, Transmitral Pressure, and Mitral Flow Rate on the Edge-To-Edge Repair: An In Vitro Study

2006 ◽  
Vol 82 (4) ◽  
pp. 1362-1368 ◽  
Author(s):  
Jorge H. Jimenez ◽  
Joseph Forbess ◽  
Laura R. Croft ◽  
Lisa Small ◽  
Zhaoming He ◽  
...  
2012 ◽  
Vol 48 (5) ◽  
pp. 506-514 ◽  
Author(s):  
Emidio M. Sivieri ◽  
Jeffrey S. Gerdes ◽  
Soraya Abbasi

1990 ◽  
Vol 15 (5) ◽  
pp. 1173-1180 ◽  
Author(s):  
Frank A. Flachskampf ◽  
Arthur E. Weyman ◽  
J.Luis Guerrero ◽  
James D. Thomas

1992 ◽  
Vol 19 (5) ◽  
pp. 998-1004 ◽  
Author(s):  
Frank A. Flachskampf ◽  
Arthur E. Weyman ◽  
Jose Luis Guerrero ◽  
James D. Thomas

1992 ◽  
Vol 15 (4) ◽  
pp. 222-228 ◽  
Author(s):  
J.C. Briceño T. ◽  
T. M. Runge

The roller pump is the most common pumping device used in extracorporeal circulation (ECC). The interaction between the roller and tubing causes tubing spallation. Spallation has been associated with complications in ECC. Previous spallation studies present mixed results, including a decrease in the number of circulating particles. The objective of this work is to perform an in vitro study of tubing spallation which elucidates the causes of the particle sequestration, and the effect of tubing material, blood flow rate and duration of the procedure upon spallation. A sampling method minimizing background counts was devised. Silicone and PVC tubing were tested under normal and tight occlusion pressure at typical cardiopulmonary bypass and hemodialysis flow rates, for circulating times up to 4 h. Occlusion pressure and flow rate highly influenced the amount of spallation produced. Particle sequestration was noted and aggregation of the plastic particles was demonstrated. We conclude that, at least in vitro, aggregation causes the decrease in the particle counts and the misleading results obtained in most spallation studies using a Coulter counter.


2017 ◽  
Vol 39 ◽  
pp. 260-265 ◽  
Author(s):  
Yasmin M. Madney ◽  
Maha Fathy ◽  
Ahmed A. Elberry ◽  
Hoda Rabea ◽  
Mohamed E.A. Abdelrahim

1981 ◽  
Author(s):  
V Musumeci ◽  
B Zappacosta

The aim of the present study was the search of changes in laboratory parameters which can be reliably correlated to the development of an effective thrombolytic state during urokinase therapy. Artificial radiolabelled venous thrombi were prepared by leaving native blood (0.1 ml) to clot in glass tubes for 2 hours in presence of 1-2 μCi of 125I fibrinogen (Sorin Saluggia, Italy). The labelled clots were introduced into a perfusion chamber (volume 0.2 ml) provided with a plastic retention screen and placed in the focus of the detector of a Pitman Ratemeter model 235 N connected to a recorder. The perfusion chamber was connected in a close circuit through a peristaltic pump to a reservoir containing citrated whole blood (15 ml) maintained at 37°C under continuous stirring. Blood was pumped through the chamber at a flow rate of 1 ml/min. Urokinase was introduced in increasing amounts in the reservoir during a period of 5 hours and at various intervals aliquots of blood (0.3 ml) were drawn and assayed after centrifugation for plasminogen, alpha 2 antiplasmin and fibrinogen. Alpha 2 antiplasmin was assayed by using Coatest Antiplasmin from Ortho Diagnostics. Plasminogen was assayed after SK activation by using the substrate S 2251 from Ortho Diagnostics. Results showed that an effective thrombolytic states, as detected by a decrease of clot radioactivity, appeared when alpha 2 antiplasmin concentration fell at levels below 40%. The alpha 2 antiplasmin measurement could be useful for monitoring the thrombolytic effectiveness of non-standard low or moderate dosages of urokinase therapy.


Sign in / Sign up

Export Citation Format

Share Document